IP Library Patent Application 10243338
Patent Application
App. No. 10/243,338

Secreted and transmembrane polypeptides and nucleic acids encoding the same

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
10/243,338
Abstract

The present invention is directed to novel polypeptides and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention.

Claims (11)

1 - 33 . (canceled)

34 . An isolated polypeptide comprising:

(a) the amino acid sequence of the polypeptide shown in FIG. 82 (SEQ ID NO: 82);

(b) the amino acid sequence of the polypeptide shown in FIG. 82 (SEQ ID NO: 82), lacking its associated signal peptide; or

(c) the amino acid sequence of the polypeptide encoded by the full-length coding sequence of the cDNA deposited under ATCC accession number PTA-1902.

35 . The isolated polypeptide of claim 34 comprising the amino acid sequence of the polypeptide shown in FIG. 82 (SEQ ID NO: 82).

36 . The isolated polypeptide of claim 34 comprising the amino acid sequence of the polypeptide shown in FIG. 82 (SEQ ID NO: 82), lacking its associated signal peptide.

37 - 38 . (canceled)

39 . The isolated polypeptide of claim 34 comprising the amino acid sequence of the polypeptide encoded by the full-length coding sequence of the cDNA deposited under ATCC accession number PTA-1902.

40 . A chimeric polypeptide comprising a polypeptide according to claim 34 fused to a heterologous polypeptide.

41 . The chimeric polypeptide of claim 40 , wherein said heterologous polypeptide is an epitope tag or a Fc region of an immunoglobulin.